CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+3.01%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$17.4B
AUM Growth
-$36.6M
(-0.21%)
Cap. Flow
-$111M
Cap. Flow
% of AUM
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
30.57%
Holding
729
New
41
Increased
319
Reduced
225
Closed
41
Top Buys
| 1 |
Waste Management
WM
|
$56.1M |
| 2 |
Microsoft
MSFT
|
$54.6M |
| 3 |
Walmart
WMT
|
$54.1M |
| 4 |
Mastercard
MA
|
$54.1M |
| 5 |
JPMorgan Chase
JPM
|
$53.2M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$77M |
| 2 |
UnitedHealth
UNH
|
$58.6M |
| 3 |
Amgen
AMGN
|
$51M |
| 4 |
IQVIA
IQV
|
$47.4M |
| 5 |
Cisco
CSCO
|
$41.7M |
Sector Composition
| 1 | Technology | 33.5% |
| 2 | Healthcare | 24.06% |
| 3 | Financials | 11.65% |
| 4 | Consumer Discretionary | 8.41% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
PayPal
PYPL
$65.1B
| $12.9M | 0.07% |
151,458
-10,361
| -6% | -$884K |
|
227
Legend Biotech
LEGN
$6.61B
| $12.8M | 0.07% |
393,452
+27,465
| +8% | +$894K |
|
228
McCormick & Company Non-Voting
MKC
$18.8B
| $12.8M | 0.07% |
167,554
+111,789
| +200% | +$8.52M |
|
229
AT&T
T
$204B
| $12.7M | 0.07% |
556,249
+34,700
| +7% | +$790K |
|
230
Essential Utilities
WTRG
$11B
| $12.7M | 0.07% |
348,481
-8,964
| -3% | -$326K |
|
231
Valero Energy
VLO
$48.6B
| $12.6M | 0.07% |
102,814
+3,264
| +3% | +$400K |
|
232
Quanta Services
PWR
$56.5B
| $12.5M | 0.07% |
39,609
-37,046
| -48% | -$11.7M |
|
233
MoonLake Immunotherapeutics
MLTX
$3.78B
| $12.3M | 0.07% |
227,476
-11,524
| -5% | -$624K |
|
234
Ferguson
FERG
$47.6B
| $12.2M | 0.07% |
70,102
+5,505
| +9% | +$956K |
|
235
Prologis
PLD
$105B
| $12.1M | 0.07% |
114,596
+15,449
| +16% | +$1.63M |
|
236
Nurix Therapeutics
NRIX
$771M
| $12M | 0.07% |
634,626
-427,333
| -40% | -$8.05M |
|
237
Burlington
BURL
$18.4B
| $11.9M | 0.07% |
41,870
+37,978
| +976% | +$10.8M |
|
238
Terns Pharmaceuticals
TERN
$628M
| $11.9M | 0.07% |
+2,153,969
| New | +$11.9M |
|
239
Pliant Therapeutics
PLRX
$106M
| $11.9M | 0.07% |
900,104
+66,888
| +8% | +$881K |
|
240
Idexx Laboratories
IDXX
$51.4B
| $11.8M | 0.07% |
28,544
+5,610
| +24% | +$2.32M |
|
241
Dell
DELL
$84.7B
| $11.7M | 0.07% |
101,812
+1,891
| +2% | +$218K |
|
242
Paycom
PAYC
$12.5B
| $11.7M | 0.07% |
56,995
+31,838
| +127% | +$6.53M |
|
243
Credicorp
BAP
$21B
| $11.3M | 0.07% |
+61,900
| New | +$11.3M |
|
244
Pfizer
PFE
$141B
| $11.2M | 0.06% |
422,501
+30,207
| +8% | +$801K |
|
245
Illinois Tool Works
ITW
$77.3B
| $11.2M | 0.06% |
43,995
+2,324
| +6% | +$589K |
|
246
Bio-Rad Laboratories Class A
BIO
$7.8B
| $11.1M | 0.06% |
33,747
+2,220
| +7% | +$729K |
|
247
Magna International
MGA
$13B
| $10.9M | 0.06% |
261,497
-25,658
| -9% | -$1.07M |
|
248
Bruker
BRKR
$4.65B
| $10.8M | 0.06% |
184,946
-195,838
| -51% | -$11.5M |
|
249
Guardant Health
GH
$7.52B
| $10.8M | 0.06% |
352,492
-13,653
| -4% | -$417K |
|
250
Avidity Biosciences
RNA
$6.36B
| $10.5M | 0.06% |
360,710
+37,314
| +12% | +$1.09M |
|